Higher Temperatures Tied to Greater Risk for Mortality in People Undergoing Dialysis
By Lori Solomon HealthDay Reporter
WEDNESDAY, April 23, 2025 -- Moderately elevated ambient temperature is associated with increased mortality in patients undergoing dialysis, according to a study published in the February issue of the Clinical Kidney Journal.
Cécile Couchoud, M.D., Ph.D., from Agence de la biomédecine in Saint Denis La Plaine, France, and colleagues conducted a retrospective cohort study to investigate the association between high temperatures and mortality for patients with chronic kidney disease stage 5 treated with dialysis or with a kidney graft (2012 to 2022). The analysis included 116,808 patients undergoing dialysis and 64,531 patients with a kidney graft.
The researchers found that between June and September during 2012 to 2022, temperatures varied from 6.7 to 45.4 degrees Celsius. During this period, there were 20,174 deaths among patients undergoing dialysis and 3,340 among patients with a kidney graft. Among those undergoing dialysis, a maximum temperature >32.5 degrees Celsius was associated with higher mortality (incidence ratio, 1.09). There was no such association observed among patients with a kidney graft.
"Further analyses are needed to confirm these results and better understand the biological and clinical impact of heat intensity and the cumulative effect with other environmental factors such as air pollution," the authors write. "More detailed studies on reasons for hospitalizations and causes of death are also planned."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Standard-Criteria Kidney Transplant Offers Clear Survival Benefit Over Continued Dialysis
TUESDAY, June 10, 2025 -- Transplantation with standard-criteria kidney offers a clear survival benefit, but this decreases with age and for those with a history of cardiovascular...
Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM
MONDAY, June 9, 2025 -- For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary...
Childhood Cancer Survivors Have Increased Risk for CKD, Hypertension
THURSDAY, May 22, 2025 -- Childhood cancer survivors (CCS) have an increased risk for chronic kidney disease (CKD) and hypertension, according to a study published online May 19...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.